Annual CFO
-$70.67 M
-$12.91 M-22.36%
December 31, 2023
Summary
- As of February 8, 2025, INZY annual cash flow from operations is -$70.67 million, with the most recent change of -$12.91 million (-22.36%) on December 31, 2023.
- During the last 3 years, INZY annual CFO has fallen by -$34.70 million (-96.46%).
- INZY annual CFO is now -648.91% below its all-time high of -$9.44 million, reached on December 31, 2018.
Performance
INZY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$24.53 M
-$870.00 K-3.68%
September 30, 2024
Summary
- As of February 8, 2025, INZY quarterly cash flow from operations is -$24.53 million, with the most recent change of -$870.00 thousand (-3.68%) on September 30, 2024.
- Over the past year, INZY quarterly CFO has dropped by -$870.00 thousand (-3.68%).
- INZY quarterly CFO is now -639.46% below its all-time high of -$3.32 million, reached on September 30, 2019.
Performance
INZY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$91.21 M
-$5.66 M-6.62%
September 30, 2024
Summary
- As of February 8, 2025, INZY TTM cash flow from operations is -$91.21 million, with the most recent change of -$5.66 million (-6.62%) on September 30, 2024.
- Over the past year, INZY TTM CFO has dropped by -$5.66 million (-6.62%).
- INZY TTM CFO is now -1624.77% below its all-time high of -$5.29 million, reached on March 31, 2019.
Performance
INZY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
INZY Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.4% | -3.7% | -6.6% |
| 3 y3 years | -96.5% | -70.3% | -57.9% |
| 5 y5 years | -648.9% | -70.3% | -57.9% |
INZY Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.8% | at low | -82.5% | +0.0% | -89.4% | at low |
| 5 y | 5-year | -275.7% | at low | -361.1% | +0.0% | -384.9% | at low |
| alltime | all time | -648.9% | at low | -639.5% | +0.0% | -1624.8% | at low |
Inozyme Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.53 M(+3.7%) | -$91.21 M(+6.6%) |
| Jun 2024 | - | -$23.66 M(-3.6%) | -$85.55 M(+10.5%) |
| Mar 2024 | - | -$24.53 M(+32.7%) | -$77.44 M(+9.6%) |
| Dec 2023 | -$70.67 M(+22.4%) | -$18.49 M(-2.0%) | -$70.67 M(+6.1%) |
| Sep 2023 | - | -$18.87 M(+21.4%) | -$66.59 M(+7.0%) |
| Jun 2023 | - | -$15.55 M(-12.5%) | -$62.23 M(+1.4%) |
| Mar 2023 | - | -$17.77 M(+23.4%) | -$61.37 M(+6.3%) |
| Dec 2022 | -$57.76 M(+20.0%) | -$14.40 M(-0.8%) | -$57.76 M(+1.7%) |
| Sep 2022 | - | -$14.51 M(-1.2%) | -$56.80 M(+4.1%) |
| Jun 2022 | - | -$14.69 M(+3.7%) | -$54.59 M(+9.3%) |
| Mar 2022 | - | -$14.16 M(+5.3%) | -$49.94 M(+3.7%) |
| Dec 2021 | -$48.15 M | -$13.44 M(+9.3%) | -$48.15 M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$12.30 M(+22.6%) | -$45.58 M(+4.8%) |
| Jun 2021 | - | -$10.03 M(-18.9%) | -$43.48 M(+3.3%) |
| Mar 2021 | - | -$12.38 M(+13.8%) | -$42.09 M(+17.0%) |
| Dec 2020 | -$35.97 M(+91.2%) | -$10.88 M(+6.6%) | -$35.97 M(+18.3%) |
| Sep 2020 | - | -$10.20 M(+18.2%) | -$30.42 M(+29.3%) |
| Jun 2020 | - | -$8.63 M(+37.8%) | -$23.54 M(+18.9%) |
| Mar 2020 | - | -$6.26 M(+17.8%) | -$19.79 M(+5.2%) |
| Dec 2019 | -$18.81 M(+99.3%) | -$5.32 M(+60.4%) | -$18.81 M(+39.4%) |
| Sep 2019 | - | -$3.32 M(-32.1%) | -$13.49 M(+32.6%) |
| Jun 2019 | - | -$4.88 M(-7.6%) | -$10.17 M(+92.4%) |
| Mar 2019 | - | -$5.29 M | -$5.29 M |
| Dec 2018 | -$9.44 M | - | - |
FAQ
- What is Inozyme Pharma annual cash flow from operations?
- What is the all time high annual CFO for Inozyme Pharma?
- What is Inozyme Pharma annual CFO year-on-year change?
- What is Inozyme Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Inozyme Pharma?
- What is Inozyme Pharma quarterly CFO year-on-year change?
- What is Inozyme Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Inozyme Pharma?
- What is Inozyme Pharma TTM CFO year-on-year change?
What is Inozyme Pharma annual cash flow from operations?
The current annual CFO of INZY is -$70.67 M
What is the all time high annual CFO for Inozyme Pharma?
Inozyme Pharma all-time high annual cash flow from operations is -$9.44 M
What is Inozyme Pharma annual CFO year-on-year change?
Over the past year, INZY annual cash flow from operations has changed by -$12.91 M (-22.36%)
What is Inozyme Pharma quarterly cash flow from operations?
The current quarterly CFO of INZY is -$24.53 M
What is the all time high quarterly CFO for Inozyme Pharma?
Inozyme Pharma all-time high quarterly cash flow from operations is -$3.32 M
What is Inozyme Pharma quarterly CFO year-on-year change?
Over the past year, INZY quarterly cash flow from operations has changed by -$870.00 K (-3.68%)
What is Inozyme Pharma TTM cash flow from operations?
The current TTM CFO of INZY is -$91.21 M
What is the all time high TTM CFO for Inozyme Pharma?
Inozyme Pharma all-time high TTM cash flow from operations is -$5.29 M
What is Inozyme Pharma TTM CFO year-on-year change?
Over the past year, INZY TTM cash flow from operations has changed by -$5.66 M (-6.62%)